Clinical, Biological, and Therapeutic Characteristics of Multiple Sclerosis in Northeastern Algeria: A Cross-Sectional Comparative Study of Relapsing-Remitting and Secondary Progressive Phenotypes
SN Comprehensive Clinical Medicine · 16.11.2026 · 8 (1)
DOI: 10.1007/s42399-026-02886-8 ↗Kurz gefasst
Querschnittstudie in der Zeitschrift SN Comprehensive Clinical Medicine, online erschienen am 16.11.2026. Verfasst von Hadjer Daoudi und 5 weiteren Autor:innen. Die Arbeit nennt 46 Literaturangaben.
Abstract (Originalsprache)
Background
Multiple sclerosis (MS) is a heterogeneous immune-mediated disease of the central nervous system with variable clinical evolution and therapeutic response. Data on the epidemiological and clinical characteristics of MS remain limited in North African populations. This study characterized the epidemiological, clinical, patient-reported environmental factors potentially associated with MS and relapse occurrence, and therapeutic profiles of MS patients in northeastern Algeria, with emphasis on differences between relapsing-remitting MS (RRMS) and secondary progressive MS (SPMS).
Methods
A cross-sectional comparative study with prospective data collection included 92 patients with confirmed MS (16–65 years) followed at the Neurology Department of the University Hospital Center of Constantine, Algeria, from March 3 to April 4, 2024. Demographic, clinical, patient-reported environmental factors potentially associated with MS and relapse occurrence, and therapeutic data were collected using a structured questionnaire and medical record review. Comparative analyses were performed between RRMS and SPMS.
Results
Women represented 69.6% of patients (female-to-male ratio 2.28). RRMS was the predominant phenotype (67.4%), followed by SPMS (32.6%); no primary progressive MS cases were identified. RRMS patients were diagnosed younger than SPMS patients (27.7 ± 8.5 vs. 34.3 ± 7.9 years, p < 0.001). Overall, 72.8% experienced at least one relapse after the initial attack, 18.5% reported a family history of MS, and vitamin D and vitamin B12 deficiencies were present in 84.8% and 46.7% of patients, respectively. Psychological stress and heat exposure were the most patient-reported factors preceding relapse. Injectable interferon therapies were the most commonly prescribed disease-modifying treatments.
Conclusions
MS in northeastern Algeria shows marked clinical heterogeneity, frequent vitamin deficiencies, and predominant use of injectable therapies. Further research, including larger multicenter longitudinal studies, is needed to better characterize treatment patterns and investigate access to a wider range of disease-modifying therapies.
Zitieren
APA
Daoudi, H., Mosrane, Y., Zeghdar, M., Benhamada, S., Eutamene, A., & Bouchlif, R. (2026). Clinical, Biological, and Therapeutic Characteristics of Multiple Sclerosis in Northeastern Algeria: A Cross-Sectional Comparative Study of Relapsing-Remitting and Secondary Progressive Phenotypes. SN Comprehensive Clinical Medicine, 8(1). https://doi.org/10.1007/s42399-026-02886-8
Vancouver
Daoudi H, Mosrane Y, Zeghdar M, Benhamada S, Eutamene A, Bouchlif R. Clinical, Biological, and Therapeutic Characteristics of Multiple Sclerosis in Northeastern Algeria: A Cross-Sectional Comparative Study of Relapsing-Remitting and Secondary Progressive Phenotypes. SN Comprehensive Clinical Medicine. 2026;8(1). doi:10.1007/s42399-026-02886-8
BibTeX
@article{Daoudi2026,
author = {Daoudi, Hadjer and Mosrane, Yousra and Zeghdar, Moufida and Benhamada, Samia and Eutamene, Aicha and Bouchlif, Rayane},
title = {Clinical, Biological, and Therapeutic Characteristics of Multiple Sclerosis in Northeastern Algeria: A Cross-Sectional Comparative Study of Relapsing-Remitting and Secondary Progressive Phenotypes},
journal = {SN Comprehensive Clinical Medicine},
year = {2026},
volume = {8},
number = {1},
doi = {10.1007/s42399-026-02886-8}
}
EUVIMED